New SEC Form D filing
INFLAMMATIX, INC., 2026-11-19
A new SEC Form D private-offering notice from Sunnyvale, CA, a $57,272,732 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Developer of host response molecular diagnostics for acute infection and sepsis, including the TriVerity blood test.
New filing todayFiled to raise $57,272,732First money in 2024-04-05Raised so far $47,421,597HQ (as filed) Sunnyvale, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Late filing
Source linked the Form D on EDGAR↗Website verified inflammatix.com↗Named in the filing 7 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Little Tomato Tech Corp., 2026-11-19, $200K, Santa Monica, CA
- Univital Inc, 2026-11-19, $2M, Woodland Hills, CA
- Crypto Insights Group Corp., 2026-11-19, $2M, San Francisco, CA
- Talos Biotech, 2026-11-19, $300K, Post Falls, ID
- BANIQL CORP., 2026-11-19, $867K, San Jose, CA
- Mosaic Biosciences, Inc., 2026-11-19, $3M, Boulder, CO
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.